Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women

ARYA Atherosclerosis

Volumn 9, Issue 3, 2013, Pages 172-178

  Asemi, Zatollah ^a   Jazayeri, Shima ^b   Najafi, Mohammad ^c   Samimi, Mansooreh ^a   Shidfar, Farzad ^b   Tabassi, Zohreh ^a   Shahaboddin, MohamadEsmaeil ^a   Esmaillzadeh, Ahmad ^d  

^a KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammation; Insulin resistance; Oxidative stress; Pregnancy

Indexed keywords

8 HYDROXYGUANINE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANALYTICAL PARAMETERS; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; OXIDATIVE STRESS; PREGNANT WOMAN;

EID: 84878039104     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Lebovitz HE, Banerji MA. Insulin resistance and its treatment by thiazolidinediones. Recent Prog Horm Res 2001; 56: 265-94.
2. Festa A, Williams K, D'Agostino R, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes 2006; 55(4): 1114-20.
3. Zeng LY. Obesity and insulin resistance. Zhonghua Yi Xue Za Zhi 2012; 92(30): 2091-2.
4. Moulana M, Lima R, Reckelhoff JF. Metabolic syndrome, androgens, and hypertension. Curr Hypertens Rep 2011; 13(2): 158-62.
5. Shi J, Zhang Y, Gu W, Cui B, Xu M, Yan Q, et al. Serum liver fatty acid binding protein levels correlate positively with obesity and insulin resistance in Chinese young adults. PLoS One 2012; 7(11): e48777.
6. Tam LS, Tomlinson B, Chu TT, Li TK, Li EK. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol 2007; 26(9): 1495-8.
7. Kim J, Xu M, Xo R, Mates A, Wilson GL, Pearsall AW, et al. Mitochondrial DNA damage is involved in apoptosis caused by pro-inflammatory cytokines in human OA chondrocytes. Osteoarthritis Cartilage 2010; 18(3): 424-32.
8. Cerasi E, Ktorza A. Anatomical and functional plasticity of pancreatic beta-cells and type 2 diabetes. Med Sci (Paris) 2007; 23(10): 885-94.
9. Poljsak B, Milisav I. The neglected significance of antioxidative stress. Oxid Med Cell Longev 2012; 2012: 480895.
10. Catalano PM, Kirwan JP, Haugel-de MS, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr 2003; 133(5 Suppl 2): 1674S-83S.
11. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107(9): 1058-70.
12. Bagul PK, Middela H, Matapally S, Padiya R, Bastia T, Madhusudana K, et al. Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacol Res 2012; 66(3): 260-8.
13. Tooke JE. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. J Diabetes Complications 2000; 14(4): 197-200.
14. Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, et al. Effect of daily consumption of probiotic yogurt on oxidative stress in pregnant women: a randomized controlled clinical trial. Ann Nutr Metab 2012; 60(1): 62-8.
15. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37(4): 277-85.
16. Stuebe AM, McElrath TF, Thadhani R, Ecker JL. Second trimester insulin resistance, early pregnancy body mass index and gestational weight gain. Matern Child Health J 2010; 14(2): 254-60.
17. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005; 46(11): 2347-55.
18. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60(3): 349-56.
19. Bo S, Signorile A, Menato G, Gambino R, Bardelli C, Gallo ML, et al. C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia. J Endocrinol Invest 2005; 28(9): 779-86.
20. McLachlan KA, O'Neal D, Jenkins A, Alford FP. Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy. Diabetes Metab Res Rev 2006; 22(2): 131-8.
21. Madan JC, Davis JM, Craig WY, Collins M, Allan W, Quinn R, et al. Maternal obesity and markers of inflammation in pregnancy. Cytokine 2009; 47(1): 61-4.
22. Clapp JF, Kiess W. Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor alpha and leptin. Am J Obstet Gynecol 2000; 182(2): 300-6.
23. Prabhu AS, Selvaraj P, Narayanan PR. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFNgamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine 2009; 45(2): 105-10.
24. Liu T, Liu Q, Yang D, Fang Z. [Relationship of serum levels of adiponectin, leptin, tumor necrosis factor-alpha and c-reactive protein with insulin resistance during first trimester pregnancy]. Zhonghua Yi Xue Za Zhi 2011; 91(15): 1058-60.
25. Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010; 53(2): 268-76.
26. Heald AH, Anderson SG, Ivison F, Laing I, Gibson JM, Cruickshank K. C-reactive protein and the insulin-like growth factor (IGF)-system in relation to risk of cardiovascular disease in different ethnic groups. Atherosclerosis 2003; 170(1): 79-86.
27. Kaaja R, Laivuori H, Pulkki P, Tikkanen MJ, Hiilesmaa V, Ylikorkala O. Is there any link between insulin resistance and inflammation in established preeclampsia? Metabolism 2004; 53(11): 1433-5.
28. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999; 353(9165): 1649-52.
29. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111(12): 1805-12.
30. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107(5): 671-4.
31. Kocic R, Pavlovic D, Kocic G, Pesic M. Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity. Vojnosanit Pregl 2007; 64(6): 391-7.
32. Sarkar P, Kar K, Mondal MC, Chakraborty I, Kar M. Elevated level of carbonyl compounds correlates with insulin resistance in type 2 diabetes. Ann Acad Med Singapore 2010; 39(12): 909-4.
33. Lindqvist H, Langkilde AM, Undeland I, Radendal T, Sandberg AS. Herring (Clupea harengus) supplemented diet influences risk factors for CVD in overweight subjects. Eur J Clin Nutr 2007; 61(9): 1106-13.
34. Tinahones FJ, Murri-Pierri M, Garrido-Sanchez L, Garcia-Almeida JM, Garcia-Serrano S, Garcia-Arnes J, et al. Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity (Silver Spring) 2009; 17(2): 240-6.
35. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol 2002; 156(3): 274-85.
36. Ge D, Gooljar SB, Kyriakou T, Collins LJ, Swaminathan R, Snieder H, et al. Association of common JAK2 variants with body fat, insulin sensitivity and lipid profile. Obesity (Silver Spring) 2008; 16(2): 492-6.
37. Lampinen KH, Ronnback M, Groop PH, Kaaja RJ. A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy. Hypertension 2008; 52(2): 394-401.
38. Yagi K, Mabuchi H. Dyslipidemia in insulin resistance and its improvement by troglitazone. Nihon Rinsho 2000; 58(2): 426-9.